- জেনেরিক নাম
- Pregabalin
- শক্তি
- 82.5 mg
- ডোজ ফর্ম
- Cr Tablet
- প্রস্তুতকারক
- Advanced Chemical Industries PLC
Gabarol CR 82.5 Extended Relea Cr Tablet
Gabarol CR 82.5 Extended Relea Cr Tablet সম্পর্কে
Gabarol CR 82.5 Extended Relea হলো Pregabalin-এর একটি ব্র্যান্ড, শক্তি ৮২.৫ mg, Cr Tablet আকারে। এটি তৈরি করে Advanced Chemical Industries PLC। Pregabalin-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Pregabalin-এর ১০৫টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম GAPA-P 150 mg Capsule-এর, প্রতি ইউনিট ৳ ১।
Gabarol CR 82.5 Extended Relea Cr Tablet কী?
Gabarol CR 82.5 Extended Release is a tablet containing pregabalin 82.5 mg in an extended-release form. Pregabalin is related to a natural calming chemical in the brain called GABA, but it does not act on GABA receptors directly. Instead it attaches to a specific site on calcium channels in the nervous system, which is thought to reduce the transmission of pain signals and to help control some types of seizure activity. It is classed as an adjunct anti-epileptic medicine. This extended-release tablet is taken as directed by the doctor, and the dose is set individually.
Gabarol CR 82.5 Extended Relea-এর ব্যবহার
Pregabalin is used for nerve pain linked to diabetes or to shingles, for fibromyalgia, and for nerve pain after spinal cord injury. It is also used alongside other medicines for partial-onset seizures. The extended-release form has its own approved uses, so ask the doctor whether Gabarol CR 82.5 Extended Release suits your condition. Only the doctor can decide if it is right for you.
Gabarol CR 82.5 Extended Relea কীভাবে ব্যবহার করবেন
Take Gabarol CR 82.5 Extended Release exactly as the doctor tells you. Swallow the extended-release tablet whole; do not crush or chew it unless the doctor or pharmacist says otherwise. Do not change the dose or stop suddenly on your own, because stopping seizure or nerve pain medicine abruptly can cause problems. Ask the doctor or pharmacist about timing with food and about missed doses.
Gabarol CR 82.5 Extended Relea-এর পার্শ্বপ্রতিক্রিয়া
Common side effects include dizziness, drowsiness, dry mouth, swelling, blurred vision, weight gain and trouble concentrating. In children treated for seizures, increased weight and appetite are common. Contact the doctor promptly if you notice swelling of the throat, head or neck, hives, trouble breathing or wheezing. Dizziness and drowsiness can affect driving and using machines. Report any troubling effect to the doctor or pharmacist.
সতর্কতা ও নিরাপত্তা
Do not take Gabarol CR 82.5 Extended Release if you are allergic to pregabalin or any ingredient in it. Tell the doctor about kidney problems, breathing problems, or medicines that make you drowsy, since breathing can be affected. Antiepileptic medicines, including pregabalin, can raise the risk of suicidal thoughts or behaviour, so tell the doctor about mood changes. There are no adequate studies in pregnant women, so pregnant women should be told of the potential risk to the fetus. Small amounts pass into breast milk, and breastfeeding is not recommended during treatment. Ask the doctor before use if pregnant, planning pregnancy or breastfeeding.
সাধারণ প্রশ্ন
What is Gabarol CR 82.5 Extended Release used for and what kind of medicine is it?
It contains pregabalin, an adjunct anti-epileptic medicine also used for certain nerve pain conditions such as diabetic nerve pain, shingles-related nerve pain, fibromyalgia and spinal cord injury nerve pain, and as add-on treatment for partial-onset seizures. The doctor will confirm whether it suits your condition.
Who should avoid it or ask the doctor first?
Anyone allergic to pregabalin or any ingredient should avoid it. Ask the doctor first if you have kidney or breathing problems, take medicines that cause drowsiness, have mood changes or suicidal thoughts, or are pregnant, planning pregnancy or breastfeeding. The doctor will decide if it is suitable.
Is it safe in pregnancy or breastfeeding?
There are no adequate, well-controlled studies of pregabalin in pregnant women, so pregnant women should be advised of the potential risk to the fetus. Small amounts pass into breast milk, and breastfeeding is not recommended during treatment. Tell the doctor if you are pregnant, planning pregnancy or breastfeeding.
Can I stop taking it on my own?
No. Do not stop or change the dose without the doctor's advice, because stopping suddenly can cause problems. The doctor decides the dose and course and will explain how to stop safely. Ask the doctor or pharmacist if you have questions about your treatment.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregabalin is indicated for:- Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
- Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
- Fibromyalgia
- Neuropathic pain associated with spinal cord injury ... Read more
- Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
- Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
- Fibromyalgia
- Neuropathic pain associated with spinal cord injury
- Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). It does not bind directly to GABAA, GABAB or benzodiazepine receptors. Pregabalin binds with high affinity to the alpha2-delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues. Although the mechanism of action of Pregabalin has not been fully elucidated, results in animal studies suggest that binding to the alpha2-delta subunit may be involved in Pregabalin's anti-nociceptive and antiseizure effects.মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Neuropathic pain associated with diabetic peripheral neuropathy in adults (DPN): The maximum recommended dose of Pregabalin is 100 mg three times a day (300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. The maximum recommended dose of Pregabalin CR capsule is 330 mg once daily.Postherpetic neuralgia in adults (PHN): The recommended dose of Pregabalin is 75 to 150 mg two times a day or 50 to 100 mg three times a day (150 to 300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 75 mg two times a day or 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 300 mg/day and who are able to tolerate Pregabalin, may be treated with up to 300 mg two times a day or 200 mg three times a day (600 mg/day).
Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 330 mg once daily and who are able to tolerate Pregabalin CR capsule, may be treated with up to 660 mg once daily. In view of the dose-dependent adverse reactions and the higher rate of treatment discontinuation due to adverse reactions, dosing above 330 mg/day should be reserved only for those patients who have on-going pain and are tolerating 330 mg daily. The maximum recommended dose of Pregabalin CR capsule is 660 mg once daily.
Management of fibromyalgia in adults: The recommended dose of Pregabalin is 300 to 450 mg/day. Dosing should begin at 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient benefit with 300 mg/day may be further increased to 225 mg two times a day (450 mg/day).
Neuropathic pain associated with spinal cord injury in adults: The recommended dose range of Pregabalin is 150 to 600 mg/day. The recommended starting dose is 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief after 2 to 3 weeks of treatment with 150 mg two times a day and who tolerate Pregabalin may be treated with up to 300 mg two times a day.
Conversion from Pregabalin capsules to Pregabalin CR capsule tablet: When switching from Pregabalin capsules to Pregabalin CR capsule tablet on the day of the switch, instruct patients to take their morning dose of Pregabalin capsule as prescribed and initiate Pregabalin CR capsule therapy after an evening meal.
Pregabalin tablet total daily dose (dosed 2 or 3 times daily): Pregabalin CR capsule capsule dose (dosed once a day)
- 75 mg/daily: 82.5 mg/day
- 150 mg/daily: 165 mg/day
- 225 mg/daily: 247.5 mg/day
- 300 mg/daily: 330 mg/day
- 450 mg/daily: 495 mg/day
- 600 mg/daily: 660 mg/day
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregabalin is unlikely to be involved in significant pharmacokinetic drug interactions.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregabalin is contraindicated in patients with known hypersensitivity to Pregabalin or any of its components.পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Most common side effects in adults are dizziness, somnolence, dry mouth, edema, blurred vision, weight gain and thinking abnormal (primarily difficulty with concentration/attention). Most common side effects in pediatric patients for the treatment of partial onset seizures are increased weight and increased appetite.গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There are no adequate and well-controlled studies with pregabalin in pregnant women. Pregnant women should be advised of the potential risk to a fetus. Small amounts of pregabalin have been detected in the milk of lactating women. Because of the potential risk of tumorigenicity, breastfeeding is not recommended during treatment with pregabalin.সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Angioedema (e.g., swelling of the throat, head and neck) can occur and may be associated with life threatening respiratory compromise requiring emergency treatment. Pregabalin should be discontinued immediately in these cases. Pregabalin should also be discontinued immediately if hypersensitivity reactions (e.g., hives, dyspnea and wheezing) occur. Antiepileptic drugs, including pregabalin, increase the risk of suicidal thoughts or behavior. Respiratory depression may occur with pregabalin when used with concomitant CNS depressants or in the setting of underlying respiratory impairment. Patients need to be monitored and dosage adjusted as appropriate. Pregabalin may cause dizziness and somnolence and impair patients ability to drive or operate machinery. Increased seizure frequency or other adverse reactions may occur if pregabalin is rapidly discontinued. Pregabalin should be withdrawn gradually over a minimum of 1 week. Pregabalin may cause peripheral edema. Caution should be exercised when coadministering pregabalin and thiazolidinedione antidiabetic agents.মাত্রাধিক্যতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
In case of overdose with pregabalin, sign and symptoms are reduced consciousness, depression/anxiety, confusional state, agitation and restlessness. Seizures and heart block have also been reported. There is no specific antidote. If indicated, elimination of unabsorbed drug may be attempted by emesis or gastric lavage; usual precautions should be observed to maintain the airway. General supportive care of the patient is indicated including monitoring of vital signs and observation of the clinical status of the patient.সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Keep in a cool & dry place (below 30°C), protected from light & moisture. Keep out of the reach of children.বিকল্প ব্র্যান্ড: Pregabalin
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।